Related Experiment Video
Updated: Aug 14, 2025

Author Spotlight: Assessing the Cardiovascular Profile of Patients with Metabolic Syndrome
Published on: September 27, 2024
Triglyceride glucose index is associated with obstructive coronary artery disease in hypertensive patients
Weili Pan1, Yongkui Ren1, Fan Yang2
1Department of Cardiology, the First Affiliated Hospital of Dalian Medical University, Dalian, Liaoning, China.
Insights
The triglyceride glucose (TyG) index is linked to a higher risk of obstructive coronary artery disease (OCAD) in patients with hypertension. Higher TyG index values indicate an increased likelihood of developing OCAD.
Area of Science:
- Cardiology
- Endocrinology
- Metabolic Syndrome
Background:
- Hypertension is a primary risk factor for coronary artery disease (CAD).
- The triglyceride glucose (TyG) index serves as a marker for insulin resistance (IR).
- Limited research exists on the association between the TyG index and the incidence of obstructive CAD (OCAD) in hypertensive individuals.
Purpose of the Study:
- To investigate the relationship between the TyG index and the incidence of OCAD in hypertensive patients.
- To determine if the TyG index can predict the development of OCAD in this population.
Main Methods:
- A retrospective study involving 1841 hypertensive patients without prior CAD history.
- Coronary computed tomography angiography (CCTA) was used to diagnose OCAD (stenosis ≥50%).
- The TyG index was calculated using fasting triglycerides and glucose levels.
Main Results:
- 310 patients (16.8%) developed OCAD.
- A J-shaped relationship was observed between TyG index and OCAD incidence.
- Elevated TyG index tertiles (T2 and T3) were significantly associated with increased OCAD risk compared to the lowest tertile (T1).
- A 1-SD increase in TyG index raised OCAD risk by 49%.
Conclusions:
- The TyG index is significantly associated with the incidence of obstructive CAD in hypertensive patients.
- The TyG index may serve as a valuable predictive marker for OCAD in hypertensive individuals.
Background:
Hypertension is a leading risk of coronary artery disease (CAD). Triglyceride glucose index (TyG) is a surrogate of insulin resistance (IR). Few studies explore the association between TyG and the incidence of obstructive CAD (OCAD) in hypertensive patients.
Methods:
We retrospectively screened 1841 hypertensive subjects who were free of a history of CAD and underwent coronary computed tomography angiography (CCTA) because of chest pain. TyG index was calculated as ln (fasting TG [mg/dL] * fasting glucose [mg/dL]/2). The outcome of this research was OCAD, which was defined as the presence of diameter stenosis ≥ 50% in any of the four major epicardial coronary arteries detected on CCTA.
Results:
A total of 310 (16.8%) patients developed obstructive CAD. The restricted cubic spline (RCS) analysis showed a J-shaped relationship between TyG and OCAD and the OR for OCAD increased as the TyG rose over 8.61 (OR perSD) 1.64, 95% CI 1.13-2.54, p = 0.008). After full adjustments for confounding covariates, patients with TyG index in tertile 3 (T3) had 2.12 times (95% CI 1.80 to 3.81) and in T2 had 2.01 times (95% CI 1.40 to 2.88) as high as the risk of OCAD compared with patients in T1 (p for trend = 0.001). When regarding TyG as a continuous variable, 1-SD increase elevated 49% (OR (95%CI), 1.49 (1.30-1.74)) risk of obstructive CAD (p = 0.007). This positive effect was still consistent across the subgroups (p for interaction > 0.05).
Conclusion:
TyG index was associated with the incidence of obstructive CAD in hypertensive patients.
More Related Videos
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
13:07Optical Coherence Tomography Based Biomechanical Fluid-Structure Interaction Analysis of Coronary Atherosclerosis Progression
Published on: January 15, 2022
Related Concept Videos
Coronary Artery Disease I: Introduction
Hypertension III: Clinical Manifestations and Diagnostic Studies
Atherosclerosis III: Management
Coronary Artery Disease IV: Preventive Measures
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease II: Pathophysiology